<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput xmlns:ns2="local" id="123082"><Title>Bayer HealthCare to develop Ardea's MEK inhibitor series worldwide for cancer indications</Title><Principal>Ardea Biosciences Inc</Principal><Partner>Bayer HealthCare AG</Partner><Type>Drug - Development/Commercialization License</Type><Status>Active</Status></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyDealSummaryOutput>